Hyperpigmentation Treatment Devices Market to Surpass US$ 2 Billion by 2026 - Coherent Market Insights

The Global Hyperpigmentation Treatment Devices Market, by Product Type (Laser Devices (Q-Switch Lasers, Non-Ablative Fractionated Resurfacing Lasers, Ablative Fractionated Resurfacing Lasers, and Picosecond Lasers), Intense Pulsed Light Devices, Radiofrequency Devices , LED Devices, and Others), by End User (Dermatology Clinics, Beauty Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1150 Mn in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2018 – 2026). Hyperpigmentation is one of the most common skin problems across the globe. According to a study published in the journal Dermatology Therapy in September 2017, melasma, which is a severe hyperpigmentation condition caused due to hormonal changes, has prevalence in the range of 1% to 50% worldwide. When effective results are not obtained by using topical treatments, device-based therapies are preferred by dermatologists. According to 2017 Plastic Surgery Statistics Report by the American Society for Plastic Surgeons, around 161,670 ablative and 426,233 non-ablative laser skin resurfacing procedures were performed in the U.S. in 2017. According to the same source, around 740,287 microdermabrasion procedures were reported in 2017. Such high number of device-based procedures are expected to drive growth of the hyperpigmentation treatment devices market. Furthermore, increasing aging population worldwide, especially in developed economies and increasing disposable income of population in emerging economies such as China, India, and Brazil are expected to fuel growth of the market. According to the International Society of Aesthetic Plastic Surgery (ISAPS) report, in 2016, Brazil, India, Turkey, Russia, and China were amongst the top 10 countries in device-based cosmetic procedures worldwide.

New product launches and acquisitions by key players are expected to drive growth of the hyperpigmentation treatment devices market

Key players are launching innovative products in the hyperpigmentation treatment devices market, in order to maintain their dominant position in the market. For instance, in July 2018, Candela Corporation was granted with the U.S. Food and Drug Administration (FDA) clearance for its Vbeam Prima, which is an advanced 595 nm pulsed dye laser that can be used for the treatment of various skin conditions such as hyperpigmentation. In April 2017, BISON MEDICAL’s CYMA clinic CO2 laser system was granted with 510(k) clearance from the U.S. FDA. It opened up strong market such as U.S. for this system. In January 2018, Cutera, Inc. launched Juliet and Secret RF to its product offerings of laser- and energy-based devices. Market players are acquiring companies to widen their product portfolio and expand their geographical presence. In March 2017, Hologic, Inc. acquired Cynosure, Inc., which is a developer, manufacturer, and supplier of wide range of light-based aesthetic and medical treatment systems.

Browse 25 Market Data Tables and 29 Figures spread through 167 Pages and in-depth TOC on “Hyperpigmentation Treatment Devices Market - by Product Type (Laser Devices (Q-Switch Lasers, Non-Ablative Fractionated Resurfacing Lasers, Ablative Fractionated Resurfacing Lasers, and Picosecond lasers), Intense Pulsed Light Devices, Radiofrequency Devices, LED Devices, and Others), by End User (Dermatology Clinics, Beauty Centers, and Others),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)”.

To know the latest trends and insights prevalent in the hyperpigmentation treatment devices market, click the link below:  

https://www.coherentmarketinsights.com/market-insight/hyperpigmentation-treatment-devices-market-2017

Key Takeaways of the Hyperpigmentation Treatment Devices Market:

• The global hyperpigmentation treatment devices market is expected to exhibit a CAGR of 7.2% over the forecast period, owing to increasing adoption of minimally invasive skin procedures using various devices such as laser device and IPL devices
• Among product type, intense pulse light devices segment is expected to hold dominant position due to higher number of procedures performed annually using these devices. However, laser devices segment is expected to exhibit high CAGR over the other products due to several new product launches by key players and faster adoption of these devices by dermatologists. In the near future, laser devices would surpass IPL devices for use in hyperpigmentation treatment.
• Among end users, dermatology clinic segment is expected to account for largest market share due to the expertise they carry in treating severe form of hyperpigmentation and affordability for costlier laser-based devices
• North America is expected to be the dominant region in the hyperpigmentation treatment devices market, followed by Latin America. According to the International Society of Aesthetic Plastic Surgery (ISAPS) report in 2016, S. accounts for 10% of the overall cosmetic procedures in the world. Also, key players are launching new products in the market, which is expected to propel growth of the market in the region. Furthermore, Asia pacific is expected to exhibit highest CAGR due to awareness about device-based treatment of hyperpigmentation and availability of skilled human resource.
• Key players operating in the global hyperpigmentation treatment devices market include Syneron Medical Ltd., Hologic, Inc., Lutronic Corporation, Alma Lasers Ltd., AMI, Venus Concept, Lumenis Ltd., Strata Skin Sciences, Inc., BISON MEDICAL, Cutera Inc., Solta Medical Inc., Lynton Lasers Ltd., and  Sciton, Inc.